KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $745,405 | -39.6% | 53,627 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,233,275 | +65014.8% | 53,644 | -16.1% | 0.00% | -50.0% |
| Q1 2023 | $1,894 | +24.0% | 63,927 | +4.4% | 0.00% | 0.0% |
| Q4 2022 | $1,528 | -99.9% | 61,220 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $1,311,000 | +21.3% | 60,227 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $1,081,000 | -29.4% | 54,888 | +51.6% | 0.00% | 0.0% |
| Q1 2022 | $1,532,000 | -28.4% | 36,208 | +7.4% | 0.00% | -33.3% |
| Q4 2021 | $2,141,000 | +9.6% | 33,727 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $1,953,000 | +46.1% | 33,253 | +20.7% | 0.00% | +50.0% |
| Q2 2021 | $1,337,000 | +201.1% | 27,557 | +141.4% | 0.00% | +100.0% |
| Q1 2021 | $444,000 | -31.7% | 11,416 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $650,000 | – | 10,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |